Navigation Links
Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun
Date:6/7/2013

BETHLEHEM, Pa., June 7, 2013 /PRNewswire/ -- Catheter-related bloodstream infections (CRBSIs), needlestick (sharps) injuries and exposure to potentially deadly blood borne pathogens continue to be major areas of concern for healthcare workers throughout the U.S.

"We are committed to addressing these issues by providing a robust portfolio of safety-engineered IV therapy devices that offer patient protection against infection and optimum safety in the workplace," said Tom Sutton, Vice President of Vascular Access Systems at B.Braun.

B. Braun Medical Inc. (B.Braun) will exhibit (booth #1316) its safety-engineered IV therapy devices at the 40th Annual Association for Professionals in Infection Control and Epidemiology (APIC) Conference, in Fort Lauderdale, Florida, June 8-10. 

B.Braun 's portfolio includes safety-engineered IV therapy devices such as:

  • Introcan Safety® IV Catheter, which is designed with innovative passive-safety features to help eliminate accidental needlestick injury - effortlessly. From insertion to catheter deployment to needle removal, clinicians are protected by a truly passive safety device that is activated automatically - no extra steps required and cannot be bypassed.
  • Introcan Safety® 3 Closed IV Catheter, B.Braun's latest innovation, which takes the same preferred passive safety-engineered needlestick protection found in Introcan Safety and adds additional protection from blood exposure. For safety and convenience, the Introcan Safety 3's unique multi-access blood control septum minimizes blood exposure during needle removal and each time the catheter hub is accessed.
  • The ULTRAPORT™ series of stopcocks, were designed in response to growing concerns about stopcock contamination. They feature disinfectable luer activated connectors that are more effective than conventional caps in preventing the passage of microorganisms in the catheter lumen. ULTRAPORT and ULTRAPORT zer0 luer-activated high-flow stopcocks, offer closed system protection against CRBSI and are designed to prevent contamination and leaks without caps. Research shows that infection control measures in the anesthesia work area may help reduce infections.1
  • Caresite® Luer Access Device, the latest in B.Braun's needleless connector portfolio that offers a safe way to access IV lines without the use of a needle, which reduces the risk of accidental needlestick injuries. Input from clinicians provided the basis for the CARESITE design. The result is a device designed to help improve patient outcomes and clinician efficiency. CARESITE needleless connector with innovative positive displacement feature is designed to help reduce catheter occlusions while preventing healthcare workers from accidental needlestick injuries.

Attendees will be able to sign-up at B.Braun's booth (#1316) to receive reprints of studies that will inform them about the infections risks to healthcare workers from needlestick injuries and blood exposure with peripheral IV catheters and about the relative safety profiles of active vs. passive safety-engineered IV catheter designs. In addition, they will be able to order reprints that will inform them about the transmission of pathogenic bacterial organisms and the prevention of intravenous bacterial injection from healthcare provider hands. 

To learn more about B.Braun visit www.bbraunusa.com

About B.Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.

1Loftus R, Koff MD, Burchman CC., et al. Transmission of pathogenic bacterial organisms in the anesthesia work area. Anesthesiology. 2008. 109:3


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Watching, Reading and Listening: A New Way to Interact with Patient Information
4. Phreesia identifies over 26% of patients who require additional autism evaluation
5. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
8. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Feb. 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... editing, today reported its fourth quarter and full ... in vivo therapeutic genome editing," said Edward ... zinc finger nuclease (ZFN) technology leads the therapeutic ... core competencies necessary to move our ground-breaking genome ...
(Date:2/9/2016)... HAMILTON, Bermuda, Feb. 9, 2016  Axovant Sciences ... focused on the treatment of dementia, today announced ... address cognitive, behavioral and functional aspects of Lewy ... people in the U.S. Two out of the ... is expected to start later this quarter. In ...
(Date:2/9/2016)... The new report "Global Diagnostic Ultrasound Devices Market Assessment & Forecast: ... global diagnostic ultrasound devices market was valued at US$ 5,381.1 million ... 2019 at a CAGR of 6.8% from 2015 to 2019. ... analyzed for six geographies of North America , ... Latin America , Middle-East and ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... February 09, 2016 , ... Cirracore Enterprise Cloud, today announced ... to the cloud. Cirracore provides a secure VMware® vCloud Air based cloud ... Transformation Solutions (TSL Partners) provides a full range of services from planning, ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... On January ... family scheduled an appointment after they noticed their furnace not producing any heat. Shortly ... heat exchanger. The cracked heat exchanger was leaking dangerous levels of carbon monoxide into ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
(Date:2/9/2016)... ... February 09, 2016 , ... ZipHearing.com is ... to affordable hearing aids , increase industry transparency, and promote awareness of ... States. , “For the average consumer, the hearing aid industry is esoteric and ...
Breaking Medicine News(10 mins):